These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6443375)
1. Impact of Talwin NX. Senay EC; Clara JR NIDA Res Monogr; 1984; 55():170-7. PubMed ID: 6443375 [No Abstract] [Full Text] [Related]
2. Abuse of pentazocine-naloxone combination. Reed DA; Schnoll SH JAMA; 1986 Nov; 256(18):2562-4. PubMed ID: 3773159 [TBL] [Abstract][Full Text] [Related]
3. The impact of the addition of naloxone on the use and abuse of pentazocine. Baum C; Hsu JP; Nelson RC Public Health Rep; 1987; 102(4):426-9. PubMed ID: 3112855 [TBL] [Abstract][Full Text] [Related]
4. Decline in abuse of pentazocine/tripelennamine (T's and Blues) associated with the addition of naloxone to pentazocine tablets. Poklis A Drug Alcohol Depend; 1984 Oct; 14(2):135-40. PubMed ID: 6510217 [TBL] [Abstract][Full Text] [Related]
5. Pentazocine (Talwin) and tripelennamine (Pyribenzamine): a new drug abuse combination or just a revival? Wadley C; Stillie GD Int J Addict; 1980 Nov; 15(8):1285-90. PubMed ID: 7216568 [TBL] [Abstract][Full Text] [Related]
6. A study of phenmetrazine (Preludin) abuse. Chambers CD; White OZ Chem Depend; 1980; 4(1-2):101-11. PubMed ID: 7226282 [No Abstract] [Full Text] [Related]
7. Pentazocine and tripelennamine: a drug abuse epidemic? Lahmeyer HW; Steingold RG Int J Addict; 1980 Nov; 15(8):1219-32. PubMed ID: 7216562 [TBL] [Abstract][Full Text] [Related]
8. Pentazocine analgesia: is there a niche for Talwin Nx? Swift JQ; Hargreaves KM Compendium; 1993 Aug; 14(8):1048, 1050 passim; quiz 1060. PubMed ID: 8269439 [TBL] [Abstract][Full Text] [Related]
9. Pentazocine (Talwin). Med Lett Drugs Ther; 1969 May; 11(10):41-2. PubMed ID: 5787904 [No Abstract] [Full Text] [Related]
10. An acute hypertensive response after intravenous use of a new pentazocine formulation. Reinhart S; Barrett SM Ann Emerg Med; 1985 Jun; 14(6):591-3. PubMed ID: 3994086 [TBL] [Abstract][Full Text] [Related]
11. Pentazocine--naloxone: another "addiction-proof" drug of abuse. Lahmeyer HW; Craig RJ Int J Addict; 1987 Nov; 22(11):1163-6. PubMed ID: 3429075 [TBL] [Abstract][Full Text] [Related]
12. A heroin maintenance program in the United States? Lewis E JAMA; 1973 Jan; 223(5):539-46. PubMed ID: 4739137 [No Abstract] [Full Text] [Related]
13. Pentazocine-naloxone: an "abuse proof" drug can be abused. Lahmeyer HW; Craig RJ J Clin Psychopharmacol; 1986 Dec; 6(6):389-90. PubMed ID: 3805342 [No Abstract] [Full Text] [Related]
14. Illicit pentazocine (Talwin) use: a report of thirteen cases. Levy RM; Brown AR; Halikas JA Int J Addict; 1972; 7(4):693-700. PubMed ID: 4659593 [No Abstract] [Full Text] [Related]
15. Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers. Comer SD; Collins ED J Pharmacol Exp Ther; 2002 Nov; 303(2):695-703. PubMed ID: 12388653 [TBL] [Abstract][Full Text] [Related]
16. Clinical experience with T's and B's. Senay EC Drug Alcohol Depend; 1985 Feb; 14(3-4):305-12. PubMed ID: 3996213 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological study of pentazocine-naloxone combination: interest as a potentially non abusable oral form of pentazocine. Legros J; Khalili-Varasteh H; Margetts G Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):11-21. PubMed ID: 6541897 [TBL] [Abstract][Full Text] [Related]
18. The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand. Robinson GM; Dukes PD; Robinson BJ; Cooke RR; Mahoney GN Drug Alcohol Depend; 1993 Jun; 33(1):81-6. PubMed ID: 8370341 [TBL] [Abstract][Full Text] [Related]
19. Physical dependence to pentazocine (Talwin): a case history. Gibson RD; Nebe FM Nebr State Med J; 1969 Oct; 54(10):689-90. PubMed ID: 4242492 [No Abstract] [Full Text] [Related]
20. Injection and non-injection drug use and infectious disease in Baltimore City: differences by race. Keen L; Khan M; Clifford L; Harrell PT; Latimer WW Addict Behav; 2014 Sep; 39(9):1325-8. PubMed ID: 24837755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]